Si-Bone (SIBN) Cash from Financing Activities (2017 - 2026)
Si-Bone's (SIBN) quarterly Cash from Financing Activities came in at $34000.0 in Q1 2026, down 66.99% year-on-year from $103000.0 in Q1 2025, and down 96.7% quarter-over-quarter from $1.0 million in Q4 2025.
Si-Bone (SIBN) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Si-Bone's Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $34000.0 for Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 66.99% year-over-year to $34000.0 in Q1 2026; TTM through Mar 2026 was $3.3 million, a 69.07% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 72.42% from the prior year.
- Cash from Financing Activities eased to $34000.0 in Q1 2026 per SIBN's latest filing, from $1.0 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $89.1 million in Q2 2023 and bottomed at -$237000.0 in Q3 2023.
- The 5-year median for Cash from Financing Activities is $169000.0 (2022), against an average of $5.8 million.
- Biggest YoY gain for Cash from Financing Activities was 7151.67% in 2023; the steepest drop was 323.58% in 2023.
- Year by year, Cash from Financing Activities stood at $693000.0 in 2022, then grew by 21.5% to $842000.0 in 2023, then slumped by 109.26% to -$78000.0 in 2024, then jumped by 1419.23% to $1.0 million in 2025, then tumbled by 96.7% to $34000.0 in 2026.
- Per Business Quant, the three latest SIBN Cash from Financing Activities figures stand at $34000.0 (Q1 2026), $1.0 million (Q4 2025), and $11000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 1.03 Mn |
| Dec 31, 2025 | 1.03 Mn |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 103,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | -78,000.00 |
| Dec 31, 2024 | -78,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 105,000.00 |
| Mar 31, 2024 | 105,000.00 |
| Dec 31, 2023 | 842,000.00 |
| Dec 31, 2023 | 842,000.00 |